European footprint Tecnimede Group is a 100% Portuguese pharmaceutical group with direct presence in Portugal, Spain, Italy, Morocco, Colombia, and Brazil, and a global reach to patients in over 100 countries, presenting opportunities for regional partnerships, distribution deals, and co-development in Europe and Latin America.

Open Innovation Recent launch of the Jorge Ruas Award as part of the Tecnimede Open Innovation Competition signals a formal channel to source innovative pharmaceutical technology and formulations, offering a strategic entry point for collaborations, licensing deals, and early-stage research partnerships.

Innovation Focus A portfolio of more than 100 products and a commitment to research, development, and production positions Tecnimede as a potential buyer or partner for licensed-in technologies, white-label manufacturing, and contract development and manufacturing (CDMO) opportunities.

Sustainability & Tech Adherence to ISO 14001 and use of advanced tools like AWS, SAP Service Cloud, PyTorch, and PRINCE2 indicate a modern, quality- and sustainability-conscious operation, suggesting collaboration prospects in sustainable supply chains, digital transformation, and data-driven clinical or operational projects.

Financial Signals Revenue range of 10 to 25 million USD and a mid-sized employee base (501-1000) imply a scalable partner for mid-market deals, including co-development, regional distribution, and joint ventures in targeted therapeutic areas aligned with Tecnimede’s global reach.